Skip to main content
. 2013 Jul 4;139(9):1507–1514. doi: 10.1007/s00432-013-1465-6

Fig. 2.

Fig. 2

Effect of belinostat on proliferation of human thyroid cancer xenografts growing in athymic mice. Graph of mean xenograft tumor volume (mm3) in belinostat-treated (100 mg/kg/5 day per week, I.P.) versus vehicle control-treated (treated similarly) mice over 52 days. Sixteen tumors (BHP2-7) were in both groups. (a) Graph of mean weights (in grams) of mice in the belinostat-treated and control-treated groups over the duration of experiment (b)